DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.
DRG and its group companies would like to inform you that we have updated our website privacy policy.
AcknowledgeIf you didn't find what you were looking for, try again!
At the end of November, I will be attending the BioPharma LatAm Convention 2016 in Mexico City, where I will have the opportunity to participate as a...
In DRG Blog/ November, 2016Since its launch, imatinib has represented the great promise of the pharmaceutical industry – a clinically successful drug for use in a high-need...
In DRG Blog/ July, 2016Desde su lanzamiento, el imatinib ha representado la gran promesa de la industria farmacéutica - un medicamento clínicamente eficaz para uso en una...
In DRG Blog/ July, 2016Until recently, Brazil – like many other oil producing countries – benefited from high oil prices, experiencing years of economic growth and...
In DRG Blog/ May, 2016Hours-long lines at the stores, empty shelves, severe rationing and fingerprint controls… this is an image one would expect after a natural disaster...
In DRG Blog/ March, 2016Waardenburg, Zlotogora, and Kabuki may initially make one think about remote and paradisiac destinations, but they refer to something more obscure and...
In DRG Blog/ February, 2016From relative obscurity, the Zika virus burst into global consciousness in early 2016 as the arbovirus spread rapidly across the Latin American region...
In DRG Blog/ February, 2016Don’t forget to attend on Jan. 19!